Format

Send to

Choose Destination
Leukemia. 2019 Aug 22. doi: 10.1038/s41375-019-0543-4. [Epub ahead of print]

MYC dysregulation in the progression of multiple myeloma.

Author information

1
Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ, USA.
2
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
3
National University of Ireland, Galway, Ireland.
4
Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
5
Department of Medicine, Mayo Clinic, Rochester, MN, USA.
6
Department of Hematology and Oncology, University Hospital Würzburg, Würzburg, Germany.
7
Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
8
Center for Cancer Research, National Institute of Health, Bethesda, MD, USA.
9
Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ, USA. bergsagel.leif@mayo.edu.
PMID:
31439946
DOI:
10.1038/s41375-019-0543-4

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center